{"as_of":"2026-08-12T05:52:00Z","caps":{"database_statements":6,"inbound":100,"outbound":100},"context_digest":"sha256:12b07af10295e7773ffd138ca83e31f2feb497eeb1f96e5a1cce57d0039c27a8","coverage":[{"denominator":118,"lane":"reference_resolution","note":"Typed states for the displayed outbound observations.","records_observed":100,"source":"paper_references, paper_reference_links","source_observed_at":"2026-08-04T09:23:25.775825Z","state":"measured"},{"denominator":101,"lane":"standing_notices","note":"One-hop event checks from named stored sources.","records_observed":101,"source":"scholarly_work_events, retraction_status_cache","source_observed_at":"2026-08-11T06:34:44.6726+00:00","state":"measured"},{"denominator":1,"lane":"inbound_itemization","note":"Pith citing papers itemized under the disclosed page cap.","records_observed":1,"source":"paper_references, paper_reference_links","source_observed_at":"2026-07-13T04:45:18.176282Z","state":"measured"},{"denominator":1,"lane":"external_citation_measurements","note":"A source-named dated measurement, never combined with another source.","records_observed":0,"source":"cited_works","source_observed_at":null,"state":"measured"}],"external_citation_measurements":[],"inbound":[{"citation":{"cited_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2510.15762","snapshot_observed_at":"2026-07-13T04:45:18.176282Z","title":"Rebecca DerSimonian and Nan Laird","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2607.09200","last_updated":"2026-07-10T08:45:12Z","snapshot_observed_at":"2026-08-06T19:02:49.801410Z","submitted_at":"2026-07-10T08:45:12Z","title":"Causal Perspectives on Network Meta-Analysis","version":1},"reference_index":11,"source":"pdf_text","source_observed_at":"2026-07-13T04:45:18.176282Z"},"links":{"cited_paper":"/paper/2510.15762","citing_paper":"/paper/2607.09200"},"observation_digest":"sha256:959e6f24a495dc56af105ff70ddf81d9f9477d82226a051af5d36481b275d6bd","observation_id":"bd9d97ce-be23-49a8-a08b-de06888e071b","resolution":{"observed_at":"2026-07-13T04:45:18.176282Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}}],"links":{"evidence":"/evidence","html":"/paper/2510.15762/citation-record","integrity":"/paper/2510.15762/integrity","json":"/paper/2510.15762/citation-record.json","paper":"/paper/2510.15762"},"outbound":[{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:14.703425Z","title":"bmj2024; 384","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":1,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:14.703425Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:1f3cb234fcb0537470f4397ec132d107318ef365f42da56e6c47f1a3d645ba8c","observation_id":"ca9e01c1-0d28-4ee6-9c37-89e5ad88d7c5","resolution":{"observed_at":"2026-08-04T09:23:14.703425Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:14.750128Z","title":"https://www.ich.org/page/ich-guideline-implementation; 2025","venue":null,"work_id":null,"year":2025},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":2,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:14.750128Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:74aae1b4926aad157ca70fcc5b19e4bb0045d0976c628e2d419cb958b72ebb99","observation_id":"456b4487-1543-47c6-93fe-f75ae12a5437","resolution":{"observed_at":"2026-08-04T09:23:14.750128Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:14.832769Z","title":"JAMA2023; 330(21): 2106–2114","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":3,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:14.832769Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:f97b05f929181162670e58efb0290c17b7e2bcd9742020c1d833a2ae726e63a6","observation_id":"dd7f3c5a-a5cb-48cd-a1d8-8a1d9a8158cd","resolution":{"observed_at":"2026-08-04T09:23:14.832769Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:14.879908Z","title":"Consensus Statement for Protocols of Factorial Randomized Trials: Extension of the SPIRIT 2013 Statement.JAMA network open2023; 6(12): e2346121","venue":null,"work_id":null,"year":2013},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":4,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:14.879908Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:83c4e1f2656fb037deac88099d9f7618914637caa4e987569eedbd4a7c12b6f3","observation_id":"c818cd44-d40a-4874-adf2-167b76de6737","resolution":{"observed_at":"2026-08-04T09:23:14.879908Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:14.933069Z","title":"Early phase clinical trials extension to guidelines for the content of statistical analysis plans.bmj2022; 376","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":5,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:14.933069Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:451bda393e780e30af670d72a1eb015d38e4fbacc4220045ccc10e85d37f0fb6","observation_id":"b09616ed-294a-468b-afff-508c8aa8738e","resolution":{"observed_at":"2026-08-04T09:23:14.933069Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:15.022120Z","title":"Defining estimands for efficacy assessment in single arm phase 1b or phase 2 clinical trials in oncology early development.Pharmaceutical Statistics2023; 22(5): 921–937","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":6,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:15.022120Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:88bb6792216fe665f8d39d5e45c3c938de29333405c2259c5efc91d4ca112fc7","observation_id":"96150817-7c63-4365-a227-fb4fdb4ec01b","resolution":{"observed_at":"2026-08-04T09:23:15.022120Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:15.114702Z","title":null,"venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":7,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:15.114702Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:e3de9dd2cbe743ce56a26bdcd3918683ffb4e140d033eec769af75ae42a14bc7","observation_id":"fbf91ec3-5959-4d86-9593-7a6a503f6c55","resolution":{"observed_at":"2026-08-04T09:23:15.114702Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:15.197914Z","title":"Review of Recent Pharmacoepidemiologic Post-Market Safety Studies Through the Lens of the Estimand Framework.Therapeutic innovation & regulatory science2025: 1–10","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":8,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:15.197914Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:de990ebc386b3c958badf47ec5adc659c1d4cc61e79840f9f34a80cfac8fd129","observation_id":"745c3286-61a4-4925-8e5c-bc218a7ecfb6","resolution":{"observed_at":"2026-08-04T09:23:15.197914Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:15.236180Z","title":"Estimands in observational studies: some considerations beyond ICH E9 (R1)","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":9,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:15.236180Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:7f2fc8f30a1632d507025980bc8c7bd76f24c23abd6809c173fe8ed182ce8a83","observation_id":"3b0a82ed-2bf5-4522-865c-f4b45a38342a","resolution":{"observed_at":"2026-08-04T09:23:15.236180Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:15.322197Z","title":null,"venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":10,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:15.322197Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:b0b361b02717d1ddb6603eee4fc211f50d297c8d644459765bba002bcc1391d7","observation_id":"70134e1f-4e5a-46e8-b6f3-b153ce0dc9d4","resolution":{"observed_at":"2026-08-04T09:23:15.322197Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:15.404555Z","title":null,"venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":11,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:15.404555Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:8e1a7661c6f4cc9b9a77adc89e21ac17556425505336699ba46b42cc767d06b1","observation_id":"5e36a380-61a3-464c-beef-75c3aa56409d","resolution":{"observed_at":"2026-08-04T09:23:15.404555Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:15.485579Z","title":"Broad versus narrow research questions in evidence synthesis: a parallel to (and plea for) estimands.Research Synthesis Methods2024; 15(5): 735–740","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":12,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:15.485579Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:54454eff98f8be97eacbb85887e99318a257c270c13fe8c7560a447a444c785c","observation_id":"866d430c-3afe-47f0-b215-b2a837182d23","resolution":{"observed_at":"2026-08-04T09:23:15.485579Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:15.575965Z","title":"Toward credible patient-centered meta-analysis.Epidemiology2020; 31(3): 345–352","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":13,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:15.575965Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:2ab686a9928d295dab94e2a8ae58e54d7e870e04661abf58c04d9c4f2f028ac8","observation_id":"9e809947-ad2d-45af-bf3e-72463166ca87","resolution":{"observed_at":"2026-08-04T09:23:15.575965Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:15.653870Z","title":"Causal inference for meta-analysis and multi-level data structures, with application to randomized studies of Vioxx.Psychometrika2017; 82(2): 459–474","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":14,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:15.653870Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:8e063f707364932182063a14329d2dd27b5f9291e07dca1e3995046f9ff2a6f5","observation_id":"7d2674aa-8749-4194-b0c2-facdf2c76e95","resolution":{"observed_at":"2026-08-04T09:23:15.653870Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:15.710003Z","title":"Toward causally interpretable meta-analysis: transporting inferences from multiple randomized trials to a new target population.Epidemiology2020; 31(3): 334–344","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":15,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:15.710003Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:3a37f765eeb1dbf4fc773451f4bd5bc835b05c12b773a4e45c627b86d10d674e","observation_id":"ade7bc24-35b1-4d2e-afbb-5613dafadcd5","resolution":{"observed_at":"2026-08-04T09:23:15.710003Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:15.810703Z","title":"Causally interpretable meta-analysis: Clearly defined causal effects and two case studies.Research Synthesis Methods2024; 15(1): 61–72","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":16,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:15.810703Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:dac0c7d169802b3a0b40b21172c178394f5c970029fe6ad37394ed727c4edc65","observation_id":"31463744-e07e-45a6-957d-f16bc07dd5e9","resolution":{"observed_at":"2026-08-04T09:23:15.810703Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:15.968695Z","title":"A review of generalizability and transportability.Annual Review of Statistics and Its Application2023; 10: 501–524","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":17,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:15.968695Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:4e685858d42e62c538a7fca8c130d89c4800db31c3872dd2f4ceaf8db4538375","observation_id":"34abd6b9-b7c3-469d-bc38-413fbd3d9292","resolution":{"observed_at":"2026-08-04T09:23:15.968695Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:16.089971Z","title":"External validity.Annual review of political science2021; 24(1): 365–393","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":18,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:16.089971Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:19ec94b76716df800ae2f70d2406cd31f52d0d95d2d2306bcc0c4f2e08c32d27","observation_id":"b1fc8863-aad2-489d-b81a-867791135aef","resolution":{"observed_at":"2026-08-04T09:23:16.089971Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:16.190277Z","title":null,"venue":null,"work_id":null,"year":2023},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":19,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:16.190277Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:6b80c9ceb1f34449453b83c27b5ad98663bcaee571df032b710439f9591bdee3","observation_id":"c9c23ad8-7e10-4e79-addd-d7ebb33e31f8","resolution":{"observed_at":"2026-08-04T09:23:16.190277Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:16.321063Z","title":null,"venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":20,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:16.321063Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:2653b7323fa711b1cdd0aa9095858d66c1096de41a4a4906d9411378d3488611","observation_id":"eba6ba8b-b473-462c-beec-d7138eb90ad0","resolution":{"observed_at":"2026-08-04T09:23:16.321063Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:16.439033Z","title":"https: //health.ec.europa.eu/latest-updates/methodological-guideline-quantitative-evidence-synthesis-direct-and-indirect- comparisons-2024-03-25_en; 2024","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":21,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:16.439033Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:eca9b26a09aac5296de67f00652ed8e459ab4d7ffaa33e108e545645ee9ba580","observation_id":"9cf4d237-3738-417f-9559-4757fcc97dc9","resolution":{"observed_at":"2026-08-04T09:23:16.439033Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:16.553586Z","title":null,"venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":22,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:16.553586Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:9870ac055a91391d38844b5a69847aedaf02ee5a9064bbc4d93f09e6df92303c","observation_id":"7f114364-e987-45bb-9453-43136809b906","resolution":{"observed_at":"2026-08-04T09:23:16.553586Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:16.612601Z","title":"Consolidated 3-year rolling work plan for the Methodology Working Party","venue":null,"work_id":null,"year":2025},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":23,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:16.612601Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:3a94d35509af633353725e3462b25017b75214d76084155aa43fec37e8dc9b9b","observation_id":"2d5ac81e-00a3-479c-83ab-cd7135fed3ae","resolution":{"observed_at":"2026-08-04T09:23:16.612601Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:16.720953Z","title":null,"venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":24,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:16.720953Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:3b7c44a0a01e13da847cfd1ab5ef92a6daa7326c017959c5ee123e850cec7670","observation_id":"0ee9e08e-64f3-425b-929f-3f43b30d1f8a","resolution":{"observed_at":"2026-08-04T09:23:16.720953Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:16.840015Z","title":"Non-Inferiority Clinical Trials to Establish Effectiveness","venue":null,"work_id":null,"year":2016},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":25,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:16.840015Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:5b1e0a5297afee19471d5a4117812ef69723291f995682e7c6d7dbf2e6f132e9","observation_id":"172849b8-4d72-4faf-834f-0a63687fc92a","resolution":{"observed_at":"2026-08-04T09:23:16.840015Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:16.939974Z","title":"ICH E9 (R1) addendum on estimands and sensitivity analysis in clinical trials to the guideline on statistical principles for clinical trials","venue":null,"work_id":null,"year":2020},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":26,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:16.939974Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:794d4883b6feabce2f9f6da98e8c6ef0978a2772083d41d76cea6805ce915ff3","observation_id":"93c7c87f-d6ec-44f1-b4cd-96e178f50ecd","resolution":{"observed_at":"2026-08-04T09:23:16.939974Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:16.999682Z","title":"REMIRO-AZÓCARET AL 23","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":27,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:16.999682Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:cc6bc97b4f7964157751b51169816a24d68a8a7215375851c1c7ceef1bbcb537","observation_id":"9e0d72e1-7df0-4590-ab68-9f6e22da185e","resolution":{"observed_at":"2026-08-04T09:23:16.999682Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:17.123336Z","title":"Estimands: bringing clarity and focus to research questions in clinical trials.BMJ open2022; 12(1): e052953","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":28,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:17.123336Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:c85c08c2343dea36e788b5444f2b2b0ad022ec9af78cb50bbe1a57a8e4011b1a","observation_id":"f6d486e5-f98a-417a-b0c1-6ffec59127ce","resolution":{"observed_at":"2026-08-04T09:23:17.123336Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:17.195681Z","title":null,"venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":29,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:17.195681Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:e84f0df97119feace387137f8a2630c75dfcd1febe4efdb733566a09fcc65689","observation_id":"48a9c64e-baef-4514-9acc-ca6880b95935","resolution":{"observed_at":"2026-08-04T09:23:17.195681Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:17.369450Z","title":null,"venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":30,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:17.369450Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:3ecaf57515854dcbe6fdef7ed9c790f440922435af564c701cca5bedd0f8135a","observation_id":"3b8322dd-b4c1-4dc3-8f3a-4c9ae8ceed58","resolution":{"observed_at":"2026-08-04T09:23:17.369450Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:17.480822Z","title":null,"venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":31,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:17.480822Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:efa28da75f2323a75f8dd0c31800ad5b0b3e6aa9cf2a769aa75b99daaa2aa731","observation_id":"99749a8f-14b7-44ef-871e-2b034ec89d85","resolution":{"observed_at":"2026-08-04T09:23:17.480822Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:17.546966Z","title":"Estimands for overall survival in clinical trials with treatment switching in oncology.Pharmaceutical Statistics2022; 21(1): 150–162","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":32,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:17.546966Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:e0a223ef2cd0e2ad1ee3b124b7dcaf53f35d72f468c7e166672ce6b45c090389","observation_id":"6f9bde0c-080d-4f0c-a338-87a0f02df5cf","resolution":{"observed_at":"2026-08-04T09:23:17.546966Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:17.611002Z","title":null,"venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":33,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:17.611002Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:adb6fec29096517a1ecb28117a761d378b518a6e3f43645e76c409f29c589592","observation_id":"07234709-f1b0-4f8a-ad73-0c2ff9618b20","resolution":{"observed_at":"2026-08-04T09:23:17.611002Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:17.712451Z","title":null,"venue":null,"work_id":null,"year":2025},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":34,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:17.712451Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:972d572a9c8a20e44424bfd213d44abc63185b54b77eedee09a7a4628dc5e4b6","observation_id":"60e7b520-34e3-4103-9872-6376f1deb6d7","resolution":{"observed_at":"2026-08-04T09:23:17.712451Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:17.746499Z","title":null,"venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":35,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:17.746499Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:6fd628a10b245669beab71c2f56828df247ea8d4012f4cf0b5326b4702f7ed18","observation_id":"58e85486-b240-4149-8ef7-7c79469bb799","resolution":{"observed_at":"2026-08-04T09:23:17.746499Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:17.853698Z","title":"Defining clinical trial estimands: a practical guide forstudyteamswithexamplesbasedonapsychiatricdisorder.Therapeutic Innovation & Regulatory Science2023;57(5): 911–939","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":36,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:17.853698Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:5dcaadc0f0a09fbb3f94995bbb45a80ee617d36cd5c075a55e654f6627ab2d04","observation_id":"e542c02f-919c-4dc2-a8f2-0ce1ae4c4104","resolution":{"observed_at":"2026-08-04T09:23:17.853698Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:17.966844Z","title":"Estimation methods for estimands using the treatment policy strategy; a simulation study based on the PIONEER 1 Trial.Pharmaceutical Statistics2025; 24(2): e2472","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":37,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:17.966844Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:16b6ae2df3e11da38baf7fb07053fca816682c1772db2c10ccfafd783276ae3a","observation_id":"6bfe89c9-615d-4fda-8693-6b50d008b792","resolution":{"observed_at":"2026-08-04T09:23:17.966844Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:18.139263Z","title":"RoB 2: a revised tool for assessing risk of bias in randomised trials.bmj2019; 366","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":38,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:18.139263Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:eddb34159e83b388da4e10ec4d06c0afd26cd8c6c120f1f71115daea3c5607c6","observation_id":"6291739d-b59c-4661-9c5e-358df2901276","resolution":{"observed_at":"2026-08-04T09:23:18.139263Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:18.250265Z","title":"https://health.ec.europa.eu/publications/ guidance-validity-clinical-studies-joint-clinical-assessments_en; 2024","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":39,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:18.250265Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:df10b7be98b4c11529646a1c27f3754fc36784d5c49556303c98dba21957a39f","observation_id":"a4e0d8af-a271-47f8-a5de-8d8f58b894ef","resolution":{"observed_at":"2026-08-04T09:23:18.250265Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:18.337637Z","title":null,"venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":40,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:18.337637Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:10acd8e1815ee15e4d0679bbec274d3c7fd6ed4546da5787b996b6c623ad211b","observation_id":"c791ea3d-9a87-467c-916b-983d50c1cebe","resolution":{"observed_at":"2026-08-04T09:23:18.337637Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:18.457752Z","title":"The well-built clinical question: a key to evidence-based decisions..ACP journal club1995; 123(3): A12–3","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":41,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:18.457752Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:717e879373c4a8dc91c8390251fc3ce4237d9bb4a6d4515c0c39a22dcdd5d1f1","observation_id":"12cfd777-d719-4cdf-b1f7-6ce8d9174fc0","resolution":{"observed_at":"2026-08-04T09:23:18.457752Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:18.619388Z","title":"https://health.ec.europa.eu/publications/guidance-outcomes-joint- clinical-assessments_en; 2024","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":42,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:18.619388Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:5a656bed5a5b097435a536f861987d089b8c462e7d801ea4592f7fd229b5d0b9","observation_id":"c644e137-6fec-4d1f-a2f2-a095f8e295a3","resolution":{"observed_at":"2026-08-04T09:23:18.619388Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:18.770434Z","title":null,"venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":43,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:18.770434Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:0e6d3bfbe6876368f3127addc5c16015059a02c267743db9965267ca2eae12ff","observation_id":"99085b55-c3f6-4af9-a051-5410fdaf6998","resolution":{"observed_at":"2026-08-04T09:23:18.770434Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:18.908588Z","title":"Preferredreporting itemsfor systematicreviews andmeta- analyses: the PRISMA statement.International journal of surgery2010; 8(5): 336–341","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":44,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:18.908588Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:ed70c5a534986d5eb7ac4223d58366d4c6e68a7263e8513b73330ebacae348b0","observation_id":"4d45d82f-d14b-4019-9d8f-b6859f3c2261","resolution":{"observed_at":"2026-08-04T09:23:18.908588Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:19.054007Z","title":"The PRISMA statement extension for systematic reviews incorporating network meta-analysis: PRISMA-NMA.Medicina Clínica (English Edition)2016; 147(6): 262–266","venue":null,"work_id":null,"year":2016},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":45,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:19.054007Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:9cab5de58178bcc05a18cd49f8eb8c75a0aede9739bb2c90c3f6997670aca270","observation_id":"b0685ef8-8ed6-4dd2-b13a-71f57323f314","resolution":{"observed_at":"2026-08-04T09:23:19.054007Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:19.192172Z","title":"The current landscape of HTA framework and key challenges.In press, Statistics in Biopharmaceutical Research2025","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":46,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:19.192172Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:f7276766aa30010b51984e9d4106f719341bba26d8f7d6c0193580e2e6dedc96","observation_id":"4e9a94cf-8f5d-48a9-a609-e54e7afd70e2","resolution":{"observed_at":"2026-08-04T09:23:19.192172Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:19.325478Z","title":"The impact of additive population (s), intervention, comparator (s), and outcomes in a European joint clinical health technology assessment.Value in Health2024; 27(12): 1722–1731","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":47,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:19.325478Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:fa5af696f4759e75215378f89044349ed11f231fbe6e999d860454d3997fb1a0","observation_id":"b9bc7513-8695-444f-b721-e72389f1ba86","resolution":{"observed_at":"2026-08-04T09:23:19.325478Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:19.423871Z","title":"Accessed: 09-07-2025","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":48,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:19.423871Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:680341ab796e1bfc729196e85879ee30035963c09b28065aed2e555d3dfa8b5f","observation_id":"3f0e0a6e-732c-402d-a1be-a079dbc2f0d4","resolution":{"observed_at":"2026-08-04T09:23:19.423871Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:19.477103Z","title":"Parametric G-computation for Compatible Indirect Treatment Comparisons with Limited Individual Patient Data.Research synthesis methods2022; 13(6): 716–744","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":49,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:19.477103Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:59d2cf61db8e2e7e3bdc0eecaeee5c58cff43acfd8d80baa7a2ee755e163582e","observation_id":"96240c0c-1324-491a-914e-af3a03bc8d2c","resolution":{"observed_at":"2026-08-04T09:23:19.477103Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:19.613342Z","title":null,"venue":null,"work_id":null,"year":2023},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":50,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:19.613342Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:aa338c3dad3d6e1c856d8452c0d4c8343f334e9c6dea807eb4c8ae58c829c265","observation_id":"d78b6130-e48c-4edf-96d4-336b0435706b","resolution":{"observed_at":"2026-08-04T09:23:19.613342Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:19.797982Z","title":null,"venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":51,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:19.797982Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:210247fd1d136c2b3f34e7727a923ec2331dd68e1a22a016a466270c372f12f9","observation_id":"765cc9e9-6881-4767-94e6-398c9ad14456","resolution":{"observed_at":"2026-08-04T09:23:19.797982Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:19.931325Z","title":"Accessed: 17-07-2025","venue":null,"work_id":null,"year":2022},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":52,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:19.931325Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:468e66e8fafee07ad161d9b3cf87a734b69c6e9f1db34ba19907bc3fad59d7e8","observation_id":"651ff983-4907-4f2d-8551-34be7b2b11e5","resolution":{"observed_at":"2026-08-04T09:23:19.931325Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:20.014379Z","title":"https://www.ema.europa.eu/en/documents/variation- report/cabometyx-h-c-004163-ii-0023-epar-assessment-report-variation_en.pdf; 2022","venue":null,"work_id":null,"year":2022},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":53,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:20.014379Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:81cb1b2643ac905f71f396caef8d1d6a62fa524915120aca4600a6562f45ee74","observation_id":"627cca91-5557-4200-8b0e-25cf98eaf0d8","resolution":{"observed_at":"2026-08-04T09:23:20.014379Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:20.156409Z","title":null,"venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":54,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:20.156409Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:39d4fd43dbc3dc8142d9580925cc510fad9b18f174b32a5ae0780e2309d69be5","observation_id":"b16ceeb4-8b50-4feb-abfc-97cbf74a8ae6","resolution":{"observed_at":"2026-08-04T09:23:20.156409Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:20.293998Z","title":"Methods Guide for Health Technology Assessment","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":55,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:20.293998Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:d70d4728a85fa66f42e49ce78c4d2383599dd163aa758f73c9b4b130792a43bf","observation_id":"b702bb54-f56c-4858-be61-ed7f5e90909a","resolution":{"observed_at":"2026-08-04T09:23:20.293998Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:20.471093Z","title":null,"venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":56,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:20.471093Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:7de6cab32bb28d4f403b296ae630d0117b12ecc4b026f9703977dd5e93a3d68b","observation_id":"8e226c65-5d7d-4aa3-9fc2-823b45e05c76","resolution":{"observed_at":"2026-08-04T09:23:20.471093Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:20.635262Z","title":"Estimands and Their Implications for Evidence Synthesis for Oncology: A Simulation Study of Treatment Switching in Meta-Analysis.arXiv preprint arXiv:2411.143232024","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":57,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:20.635262Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:b6c3c1248eee41c87b6e37eabcce484427d00e15bfda1f45d0337cdb807a916d","observation_id":"baaa730e-a4c4-442a-a328-abced9a821ce","resolution":{"observed_at":"2026-08-04T09:23:20.635262Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:20.779210Z","title":null,"venue":null,"work_id":null,"year":2025},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":58,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:20.779210Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:f77cb8460b0d2f20ded25d206f79418e1937cd5c022a77c5c7373c7ac6584cf2","observation_id":"e563474e-4a64-4cf0-b75e-946f8cc5bea2","resolution":{"observed_at":"2026-08-04T09:23:20.779210Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:20.868745Z","title":null,"venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":59,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:20.868745Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:0b3314465464976e2cfbe6367977ce0cc4c5e3a39039bdd18f661b188a9e837d","observation_id":"d0c7680f-324b-4349-b45e-423b9e5754eb","resolution":{"observed_at":"2026-08-04T09:23:20.868745Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:21.037714Z","title":"Estimand Framework and Statistical Considerations for Integrated Analysis of Clinical Trial Safety Data.Therapeutic Innovation & Regulatory Science2024; 58(6): 1120–1128","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":60,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:21.037714Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:104d95c36552a2dde80fb3e7242f4c18220567f8bf11f0334edd07d9601a8ebe","observation_id":"6e059f41-2216-4d82-b500-0bc9a7a8f1fe","resolution":{"observed_at":"2026-08-04T09:23:21.037714Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:21.178278Z","title":"Diabetes care2020; 43(2): 487–493","venue":null,"work_id":null,"year":2018},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":61,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:21.178278Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:e14067d1367ed541f43a384c4bd4742b49b620fdc42053dfef67cb1c2e5f9944","observation_id":"cb008c52-5bb8-4533-90a7-aba2145db7a8","resolution":{"observed_at":"2026-08-04T09:23:21.178278Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:21.295786Z","title":"Efficacy and safety of GLP-1 receptor agonists across the spectrum of type 2 diabetes mellitus","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":62,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:21.295786Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:b154456cdb31335f08b5af8d48df1f5ef3e4238d507942e4cf9dca4c06529923","observation_id":"8851e840-7234-4e30-94b0-b761b24702a2","resolution":{"observed_at":"2026-08-04T09:23:21.295786Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:21.445473Z","title":null,"venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":63,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:21.445473Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:43ab6842e9b54a090236f50b8118473bb01a42a9ba818abaa7d9ac161e89dd12","observation_id":"41b1ef6b-3ba1-4b23-9c64-06182764b234","resolution":{"observed_at":"2026-08-04T09:23:21.445473Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:21.592518Z","title":"Defining and characterizing the progression of type 2 diabetes.Diabetes care2009; 32(Suppl 2): S151","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":64,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:21.592518Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:61a04ad84462e6577609a06e2671f625b403965c6771e2c360087e31e7bb9851","observation_id":"7075f99f-8d7e-49e2-b742-8c4cee2800e8","resolution":{"observed_at":"2026-08-04T09:23:21.592518Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:21.752042Z","title":null,"venue":null,"work_id":null,"year":2021},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":65,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:21.752042Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:ae4b159478bce0a4a11d8e4e315a91534ae7d60afb4d805db08e1bc457708985","observation_id":"8bfce8f4-4ca5-470e-9040-0c7c8a743c84","resolution":{"observed_at":"2026-08-04T09:23:21.752042Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:21.856889Z","title":null,"venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":66,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:21.856889Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:55ddd30e243b4329435de5bc1f21af33c3619707066caacd4a5c3710fbd6fc4d","observation_id":"d19c2f6c-c00a-47de-a5e2-8f239c5de451","resolution":{"observed_at":"2026-08-04T09:23:21.856889Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:21.941982Z","title":"Risk of bias in network meta-analysis (RoB NMA) tool.bmj2025; 388","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":67,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:21.941982Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:bfc052e905134e6ee6fb856ce1c0e853afa845265afeaca053ac0c0850e7f908","observation_id":"f2b7f89f-fa8c-45bf-8ff9-34113d18d46c","resolution":{"observed_at":"2026-08-04T09:23:21.941982Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:22.006880Z","title":"https://cdn.clinicaltrials.gov/large-docs/04/NCT02648204/Prot_000.pdf; 2015","venue":null,"work_id":null,"year":2015},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":68,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:22.006880Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:4dd7e78ce99c6dbdfe596ff0b107413bc8dac5661c79ac653af8d9682c7f1356","observation_id":"fb610178-9ebe-4052-9530-f435ce592caf","resolution":{"observed_at":"2026-08-04T09:23:22.006880Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:22.054807Z","title":"https://cdn.clinicaltrials.gov/large-docs/04/NCT02648204/SAP_001.pdf; 2017","venue":null,"work_id":null,"year":2017},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":69,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:22.054807Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:3a033219b37a60f58885e59d67b831f139a31221eab163058fd6c60c19fc669e","observation_id":"c9c7c221-1714-4ba9-a4f5-8458ef37cb0a","resolution":{"observed_at":"2026-08-04T09:23:22.054807Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:22.125932Z","title":"https://cdn.clinicaltrials.gov/large-docs/32/NCT03989232/Prot_000.pdf; 2020","venue":null,"work_id":null,"year":2020},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":70,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:22.125932Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:20ca40269c8286570e24545ef3b5446966949e0f5709d313ecd23846547795e3","observation_id":"50805e0f-3ab6-498d-b6a4-40d7ae70ffe4","resolution":{"observed_at":"2026-08-04T09:23:22.125932Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:22.171772Z","title":"once-weekly compared to semaglutide 1.0 mg s.c","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":71,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:22.171772Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:d9f2d3532868c0150785e782626ab777e5af780e50269a9c2b5ffbfd0092b930","observation_id":"eea8c954-6311-49b5-a8a7-ad71022f4901","resolution":{"observed_at":"2026-08-04T09:23:22.171772Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:22.311048Z","title":"https://cdn.clinicaltrials.gov/large-docs/02/ NCT03495102/Prot_000.pdf; 2018","venue":null,"work_id":null,"year":2018},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":72,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:22.311048Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:505363c8c5b7e5f5f6dd510a70049c013af5d280c0baa63fdb1026c09a6c5259","observation_id":"2ec45f72-018a-4609-a241-f245e2c8122f","resolution":{"observed_at":"2026-08-04T09:23:22.311048Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:22.355467Z","title":"Accessed: 22-07-2025","venue":null,"work_id":null,"year":2019},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":73,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:22.355467Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:774de6d7ec6216befc22d8286a586d1461b7f47ab11518d8f252ea34ef826006","observation_id":"c94333c3-9c1e-40e8-8183-73c0a89d68ca","resolution":{"observed_at":"2026-08-04T09:23:22.355467Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:22.460563Z","title":null,"venue":null,"work_id":null,"year":2018},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":74,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:22.460563Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:d0095af3ebaec00bbe2b4848f10de8bbdf43b33faca45b0453787fda484fb7e3","observation_id":"ee32b916-1af8-4dd2-ad99-8b7595d71c53","resolution":{"observed_at":"2026-08-04T09:23:22.460563Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:22.520628Z","title":null,"venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":75,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:22.520628Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:79d85424127179a135ef969fd7d2d211cdc66359613bc7755a13b2757cf2deac","observation_id":"4c0dab40-25e6-4b89-92b7-25e36ca4e780","resolution":{"observed_at":"2026-08-04T09:23:22.520628Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:22.693909Z","title":"A basic introduction to fixed-effect and random-effects models for meta-analysis.Research synthesis methods2010; 1(2): 97–111","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":76,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:22.693909Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:a89a11899c9c9c05446d82477ff13a7cc20d38bb3f654c14d95a6ff11828ebdf","observation_id":"d77c42cd-3684-45ce-bcd2-e3d16a55d2c2","resolution":{"observed_at":"2026-08-04T09:23:22.693909Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:22.862250Z","title":null,"venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":77,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:22.862250Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:7a4004bc48efeb33b0a9f2ea178f19628f4bed6bd8ff1650bdadb4e9472fd7be","observation_id":"0b23bea3-1b2e-45e3-a029-3e870bfd59cf","resolution":{"observed_at":"2026-08-04T09:23:22.862250Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:23.004417Z","title":"netmeta: an R package for network meta-analysis using frequentist methods.Journal of Statistical Software2023; 106: 1–40","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":78,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:23.004417Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:5c4d1ea7be7b5ac0bdceb83839abec60dccd1d7506e6ac2dea72b1424e81a79e","observation_id":"2cb86bbf-5db4-484b-89e8-2517e0e4e2d6","resolution":{"observed_at":"2026-08-04T09:23:23.004417Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:23.191229Z","title":"John Wiley & Sons","venue":null,"work_id":null,"year":2019},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":79,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:23.191229Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:cc53251430c3b136f92c4bf29066e62e8d27ed910a199d76f505f74c2f09a4ae","observation_id":"68561c0b-6313-419c-a126-e3cfd8ebf37e","resolution":{"observed_at":"2026-08-04T09:23:23.191229Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:23.363564Z","title":"Choosing estimands in clinical trials: putting the ICH E9 (R1) into practice","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":80,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:23.363564Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:cea57c54e270061b59f08a9bb2ab7ec17fe9ff5bda360a358f165d11c9db74b8","observation_id":"18645faa-acf4-432a-a071-efc5253e8e19","resolution":{"observed_at":"2026-08-04T09:23:23.363564Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:23.507750Z","title":null,"venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":81,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:23.507750Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:860390373f30a6f78b3cbfb5c177299444bb830f5b1d71e521649819b4e78f57","observation_id":"151dd23a-fd6a-4a83-8a10-4b5682336ab4","resolution":{"observed_at":"2026-08-04T09:23:23.507750Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:23.625989Z","title":"efficacy-effectiveness gap","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":82,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:23.625989Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:4d9b3dea10c1f1881c35aa6beab9ad1e37cba4510fd28438996ca95b593e0d35","observation_id":"c780d585-3306-4457-8ffa-06c77a3628c3","resolution":{"observed_at":"2026-08-04T09:23:23.625989Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:23.709682Z","title":null,"venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":83,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:23.709682Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:5fe6f1147a075d718fb3bed5ec7e009e2abf2db24d2f9ccd5392b97b5c7192c2","observation_id":"e625c3ec-d719-4909-ac54-132659f3be09","resolution":{"observed_at":"2026-08-04T09:23:23.709682Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:23.830557Z","title":"Adherence to glucagon-like peptide-1 receptor agonist treatment in type 2 diabetes mellitus: a nationwide registry study.Diabetes, Obesity and Metabolism2024; 26(11): 5239–5250","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":84,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:23.830557Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:76eb2c7655d32175f5074df4a9e9ebdf003da5b9c07c6ddee9777ae111af14a3","observation_id":"1862eee8-bee6-49ae-8221-19ad354d1b10","resolution":{"observed_at":"2026-08-04T09:23:23.830557Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:23.942802Z","title":null,"venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":85,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:23.942802Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:8a076e29cf340c548c1b4edc206b91d34727a65a27bee3741966e3fa064975d3","observation_id":"50d25ff2-25b7-4de5-80ab-020f8789272a","resolution":{"observed_at":"2026-08-04T09:23:23.942802Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:24.089913Z","title":null,"venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":86,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:24.089913Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:ff29213da1b739d835b4cbf58718ad792bb7a043b7c14d2255a3421568821a99","observation_id":"07b334ae-7f4a-41ea-9b3c-fc32af1846e4","resolution":{"observed_at":"2026-08-04T09:23:24.089913Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:24.230988Z","title":null,"venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":87,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:24.230988Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:0a120ccd77e7b73fbba783c40f5a18be7229416014ee6fee5874b5975a2e2bb5","observation_id":"7bc17f93-afc2-4451-986b-eaf188a2fa54","resolution":{"observed_at":"2026-08-04T09:23:24.230988Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:24.380234Z","title":null,"venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":88,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:24.380234Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:0997cb60f565504cceef77358de2c0ff5633d93fa66e71d2999fd6ec98031599","observation_id":"30f751e6-a84c-4dca-bc88-23225e38cf65","resolution":{"observed_at":"2026-08-04T09:23:24.380234Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:24.527261Z","title":"Treatment switching in evidence synthesis in oncology: A systematic review of current meta-analytical practices.Under review, Research Synthesis Methods2025","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":89,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:24.527261Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:a8bdadea0a518535e00d328d0511e1b77e610dc1e9b42c60c1332ba9e289d967","observation_id":"d30f4149-c19d-4407-9884-940b40857b26","resolution":{"observed_at":"2026-08-04T09:23:24.527261Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:24.670468Z","title":"https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-clinical-investigation-medicinal-products- treatment-or-prevention-diabetes-mellitus-revision-2_en.pdf; 2023","venue":null,"work_id":null,"year":2023},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":90,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:24.670468Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:e540e554de814ffddc77ac922af3b62fb670689fc0a9710628e275f89afefaec","observation_id":"3bbdd83e-a35d-4436-9f69-c6f304293e50","resolution":{"observed_at":"2026-08-04T09:23:24.670468Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:24.815675Z","title":"https://www.ema.europa.eu/en/documents/other/joint-htab-regulatory-perspectives-understanding- evidence-challenges-managing-uncertainties-exploring-potential-solutions_en.pdf; 2025","venue":null,"work_id":null,"year":2025},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":91,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:24.815675Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:4c3b0f4d2bb0c5f3fcf28cc44190ecba39658b3e949a87b72d8e2ce031fa311b","observation_id":"5b8980d2-81ff-4f2e-976d-3aedf674bcc9","resolution":{"observed_at":"2026-08-04T09:23:24.815675Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:24.936724Z","title":null,"venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":92,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:24.936724Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:d79082684060082d392b5169cb58692d847715582b88d3df65e3d378746e9c7e","observation_id":"f08481a2-5264-42cd-b8e9-991f2c4f7784","resolution":{"observed_at":"2026-08-04T09:23:24.936724Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:25.050177Z","title":"Using individual participant data to improve network meta-analysis projects.BMJ evidence-based medicine2023; 28(3): 197–203","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":93,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:25.050177Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:d3ab9eca6e05fe5b1ec9c1af228185b10991602c5391d828dcc7cb524901579b","observation_id":"c929e114-44dd-43a0-92b9-779f74d55f4d","resolution":{"observed_at":"2026-08-04T09:23:25.050177Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:25.159443Z","title":null,"venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":94,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:25.159443Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:565c47bf24532c498b5041382990b4052d3143ceecf22547667a2c3dfdc38c77","observation_id":"1e0ae92f-e9ad-4c37-9ca2-826fd3b93544","resolution":{"observed_at":"2026-08-04T09:23:25.159443Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:25.253729Z","title":"Modelling time-course relationships with multiple treatments: Model-based network meta-analysis for continuous summary outcomes.Research synthesis methods2019; 10(2): 267– 286","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":95,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:25.253729Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:d0dbd197bfdae115c350c43b19027f5748f9a125cad3d34230a13e6a8f41367e","observation_id":"d259d197-667e-4d47-ae3b-66f7c51ce9f2","resolution":{"observed_at":"2026-08-04T09:23:25.253729Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:25.354328Z","title":"Performance of model-based network meta-analysis (MBNMA) of time-course relationships: a simulation study.Research Synthesis Methods2020; 11(5): 678–697","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":96,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:25.354328Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:625c8fa2331725925c08a2597b2abe16cc7af41adce15df0f138845032b12ce2","observation_id":"0cb6cb62-a752-408f-ab5b-7c3de26b67e8","resolution":{"observed_at":"2026-08-04T09:23:25.354328Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:25.476102Z","title":"On estimands and the analysis of adverse events in the presence of varying follow-up times within the benefit assessment of therapies.Pharmaceutical Statistics2019; 18(2): 166–183","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":97,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:25.476102Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:14aed50ac475e48d8a24e65c78cadeee3ba407a14cfd83b8de9e5f2269c3af20","observation_id":"06e30f44-b2db-432c-b632-05239285abbb","resolution":{"observed_at":"2026-08-04T09:23:25.476102Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:25.615804Z","title":"Impact of patient characteristics on efficacy and safety of once-weekly semaglutide versus dulaglutide: SUSTAIN 7 post hoc analyses.BMJ open2020; 10(11): e037883","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":98,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:25.615804Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:666f675a7d05b91b644cbf8277ac92eeb70394ffff9466124e8e4c0e9c72797c","observation_id":"0ecc6b37-b359-4afa-ad06-7ba06dae6679","resolution":{"observed_at":"2026-08-04T09:23:25.615804Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:25.700666Z","title":"NICE DSU technical support document 18: methods for population-adjusted indirect comparisons in submissions to NICE","venue":null,"work_id":null,"year":2016},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":99,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:25.700666Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:ca9f62e4fecd6e407540e5ec606c5057b86c14ff4753c076f1894b8b7509177f","observation_id":"99364183-1a5f-496b-b63e-ce116d5af47e","resolution":{"observed_at":"2026-08-04T09:23:25.700666Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-04T09:23:25.775825Z","title":"Random-effects model for meta-analysis of clinical trials: an update.Contemporary clinical trials2007; 28(2): 105–114","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials","version":3},"reference_index":100,"source":"pdf_text","source_observed_at":"2026-08-04T09:23:25.775825Z"},"links":{"citing_paper":"/paper/2510.15762"},"observation_digest":"sha256:e403e9459601bc788a997dea6de183f75bee5780d3d2aec1a9185adf761246dd","observation_id":"a249b16e-a9d6-4fd5-aa31-f9ab5b9fda47","resolution":{"observed_at":"2026-08-04T09:23:25.775825Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}}],"paper":{"arxiv_id":"2510.15762","last_updated":"2026-05-31T11:47:23Z","latest_version":3,"primary_category":"stat.AP","snapshot_observed_at":"2026-08-11T01:58:02.645394Z","submitted_at":"2025-10-17T15:52:04Z","title":"Incorporating estimands into meta-analyses of clinical trials"},"reference_resolution":{"displayed":100,"state_counts":{"malformed_identifier":0,"metadata_mismatch":0,"parse_uncertain":0,"unresolved":100,"verified_exact":0,"verified_fuzzy":0},"total_outbound_references":118},"refusal":"A citation records a reference. It does not transfer a finding from one paper to another.","schema":"pith.paper-citation-record.v1","standing_sources":[{"observed_at":"2026-08-11T06:34:44.6726+00:00","source":"crossref"},{"observed_at":"2026-08-11T06:34:36.301508+00:00","source":"retraction_watch"}],"thesis":"As of 12 August 2026, this Paper Citation Record lists 100 of 118 outbound references and 1 inbound Pith citation observation for arXiv:2510.15762."}